Transtech Optelecom Science Holdings Limited (“Transtech”) has entered into a placing agreement with Innovax Securities, Patrons Securities and Canton Mutual Financial to issue up to 40.00 million new shares at HK$7.00 each under its existing general mandate. The transaction, announced on 14 August 2026 after market close, is on a best-effort basis and targets no fewer than six independent professional or institutional investors.
The proposed Placing Shares represent 11.50% of Transtech’s current issued share capital and 10.30% of the enlarged share base, assuming full placement and no other changes to outstanding shares. The HK$7.00 placing price is set at an 8.50% discount to the 14 August closing price of HK$7.65 and an 11.50% discount to the five-day average of HK$7.91.
If fully subscribed, the offer will raise gross proceeds of HK$280.00 million and net proceeds of approximately HK$279.30 million, implying a net price of HK$6.98 per share after commissions and expenses. All new shares will rank pari passu with existing shares and be subject to a six-month lock-up for placees.
Proceeds allocation: • 40% (HK$111.60 million) – purchase of key raw materials such as silicon tetrachloride and germanium tetrachloride to secure supply and stabilise costs. • 17% (HK$47.43 million) – expand optical-fibre capacity at Futong (Thailand) Co., Ltd. to capture Southeast Asian demand. • 15% (HK$41.85 million) – strengthen R&D in hollow-core, polarisation-maintaining and G.654.E ultra-low-loss fibres, covering staffing, equipment and trial production. • 13% (HK$36.30 million) – resume optical-fibre production at Transtech Optical Communication Company Limited in Hong Kong. • 15% (HK$41.90 million) – general working capital.
Post-placement, Hong Kong Futong Optical Fiber Company Limited will see its stake diluted from 56.14% to 50.34%, while Optel Technology Limited’s holding will fall from 13.92% to 12.49%. Public float will decline to 26.84%, and new placees will collectively own 10.33% of the enlarged 387.34 million shares outstanding.
Completion is conditional on Stock Exchange approval for listing the new shares and other customary conditions to be met by 31 August 2026. The placing can be terminated by the agents under specified adverse market or company-specific events. Transtech states the transaction will broaden its shareholder base and enhance liquidity while bolstering its balance sheet for raw-material procurement, capacity expansion, R&D and working-capital needs.
Comments